Pilar Arques-Bello

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Treatment with radionuclide-labeled peptides in refractory meningiomas: Updated review and clinical perspectives.

Treatment with radionuclide-labeled peptides in refractory meningiomas: Updated review and clinical perspectives.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: May 21, 2025

Radio theranostics in paragangliomas and pheochromocytomas.

Radio theranostics in paragangliomas and pheochromocytomas.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: April 20, 2024

Update on iodine-refractory differentiated thyroid carcinoma.

Update on iodine-refractory differentiated thyroid carcinoma.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: May 24, 2023

Same-day comparative protocol PET/CT-PET/MRI [68 Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.

Same-day comparative protocol PET/CT-PET/MRI [68 Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: October 10, 2022

The sentinel node with technetium-99m for prostate cancer. A safe and mature new gold standard?

The sentinel node with technetium-99m for prostate cancer. A safe and mature new gold standard?

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: June 28, 2022

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.

Journal: Frontiers in endocrinology
Published: May 30, 2022

Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE.

Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: October 07, 2021

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.

Journal: Frontiers in endocrinology
Published: September 16, 2021

The Role of Imaging Studies in Favor of Possible Cerebellar Multiple System Atrophy: A Case Study.

The Role of Imaging Studies in Favor of Possible Cerebellar Multiple System Atrophy: A Case Study.

Journal: Clinical nuclear medicine
Published: June 26, 2021

The value of 18F-FDG PET/CT in two cases of Primary Pericardial Mesothelioma.

The value of 18F-FDG PET/CT in two cases of Primary Pericardial Mesothelioma.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 07, 2021

A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan.

A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: July 20, 2020

Pericardial synovial tumor, a rare entity to diagnose by imaging.

Pericardial synovial tumor, a rare entity to diagnose by imaging.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: June 27, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026